黃山旅遊(600054.SH)終止與黃山京黟旅遊簽署的合作框架協議
格隆匯12月25日丨黃山旅遊(600054.SH)公佈,公司於2016年11月與黃山京黟旅遊開發有限公司等相關合作方就宏村項目合作事宜簽署了《合作框架協議》。自該協議簽署以來,公司積極與合作方進行了充分溝通和磋商,並對標的公司開展了盡職調查、審計評估等相關工作。由於在該項目推進過程中,雙方未就關鍵問題達成一致意見,且黃山京黟公司亦在積極尋找其他合作方,鑑此,經審慎考慮並與合作方協商一致,公司決定終止本次合作框架協議。
公司稱,公司將繼續圍繞既定的“山水村窟”戰略,利用徽州古村落的地域與文化優勢,尋求更多的發展機會,推動公司持續健康發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.